These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35840033)

  • 1. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.
    Carr JP; MacLennan JM; Plested E; Bratcher HB; Harrison OB; Aley PK; Bray JE; Camara S; Rodrigues CMC; Davis K; Bartolf A; Baxter D; Cameron JC; Cunningham R; Faust SN; Fidler K; Gowda R; Heath PT; Hughes S; Khajuria S; Orr D; Raman M; Smith A; Turner DPJ; Whittaker E; Williams CJ; Zipitis CS; Pollard AJ; Oliver J; Morales-Aza B; Lekshmi A; Clark SA; Borrow R; Christensen H; Trotter C; Finn A; Maiden MC; Snape MD;
    Clin Microbiol Infect; 2022 Dec; 28(12):1649.e1-1649.e8. PubMed ID: 35840033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.
    Carr J; Plested E; Aley P; Camara S; Davis K; MacLennan JM; Gray S; Faust SN; Borrow R; Christensen H; Trotter C; Maiden MCJ; Finn A; Snape MD;
    BMJ Open; 2020 Oct; 10(10):e037358. PubMed ID: 33093030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.
    Oldfield NJ; Green LR; Parkhill J; Bayliss CD; Turner DPJ
    J Infect Dis; 2018 Jan; 217(4):608-616. PubMed ID: 29155998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
    Read RC; Baxter D; Chadwick DR; Faust SN; Finn A; Gordon SB; Heath PT; Lewis DJ; Pollard AJ; Turner DP; Bazaz R; Ganguli A; Havelock T; Neal KR; Okike IO; Morales-Aza B; Patel K; Snape MD; Williams J; Gilchrist S; Gray SJ; Maiden MC; Toneatto D; Wang H; McCarthy M; Dull PM; Borrow R
    Lancet; 2014 Dec; 384(9960):2123-31. PubMed ID: 25145775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results.
    MacLennan JM; Rodrigues CMC; Bratcher HB; Lekshmi A; Finn A; Oliver J; Wootton M; Ray S; Cameron C; Smith A; Heath PT; Bartolf A; Nolan T; Hughes S; Varghese A; Snape MD; Sewell R; Cunningham R; Stolton A; Kay C; Palmer K; Baxter D; Suggitt D; Zipitis CS; Pemberton N; Jolley KA; Bray JE; Harrison OB; Ladhani SN; Pollard AJ; Borrow R; Gray SJ; Trotter C; Maiden MCJ
    Lancet Infect Dis; 2021 May; 21(5):677-687. PubMed ID: 33482143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine.
    Read RC; Dull P; Bai X; Nolan K; Findlow J; Bazaz R; Kleinschmidt A; McCarthy M; Wang H; Toneatto D; Borrow R
    Vaccine; 2017 Jan; 35(3):427-434. PubMed ID: 27912986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
    Nunes AM; Ribeiro GS; Ferreira ÍE; Moura AR; Felzemburgh RD; de Lemos AP; Reis MG; de Moraes JC; Campos LC
    PLoS One; 2016; 11(11):e0166475. PubMed ID: 27861618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis.
    McMillan M; Chandrakumar A; Wang HLR; Clarke M; Sullivan TR; Andrews RM; Ramsay M; Marshall HS
    Clin Infect Dis; 2021 Aug; 73(3):e609-e619. PubMed ID: 33212510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.
    Mbaeyi S; Pondo T; Blain A; Yankey D; Potts C; Cohn A; Hariri S; Shang N; MacNeil JR
    JAMA Pediatr; 2020 Sep; 174(9):843-851. PubMed ID: 32687590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial.
    Dbaibo G; El-Ayoubi N; Ghanem S; Hajar F; Bianco V; Miller JM; Mesaros N
    Drugs Aging; 2013 May; 30(5):309-19. PubMed ID: 23494214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trial.
    Badahdah AM; Bakarman MA; Khatami A; Tashani M; Barasheed O; Alfelali M; Azeem MI; Bokhary H; Soltan O; Lahra MM; Jeoffreys N; Kok J; Dwyer DE; Booy R; Rashid H;
    J Travel Med; 2020 Jul; 27(4):. PubMed ID: 32125434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018.
    Blain AE; Reese HE; Marjuki H; Topaz N; Mbaeyi S; McNamara LA
    Vaccine; 2021 Dec; 39(52):7541-7544. PubMed ID: 34802785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil.
    Ferreira VM; Ferreira ÍE; Chang HY; Nunes AMPB; Topaz N; Pimentel ER; Moura ARSS; Ribeiro GS; Feitosa CA; Reis MG; Wang X; Campos LC
    Vaccine; 2020 Mar; 38(14):2995-3002. PubMed ID: 32115294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine.
    Ruiz Garcia Y; Abitbol V; Pellegrini M; Bekkat-Berkani R; Soumahoro L
    Infect Dis Ther; 2022 Apr; 11(2):639-655. PubMed ID: 34591258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys.
    Mbaeyi S; Sampo E; Dinanibè K; Yaméogo I; Congo-Ouédraogo M; Tamboura M; Sawadogo G; Ouattara K; Sanou M; Kiemtoré T; Dioma G; Sanon B; Somlaré H; Kyetega A; Ba AK; Aké F; Tarbangdo F; Aboua FA; Donnou Y; Kamaté I; Patel JC; Schmink S; Spiller MW; Topaz N; Novak R; Wang X; Bicaba B; Sangaré L; Ouédraogo-Traoré R; Kristiansen PA
    Lancet Infect Dis; 2020 Dec; 20(12):1418-1425. PubMed ID: 32653071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
    Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study.
    Ohm M; Hahné SJM; van der Ende A; Sanders EAM; Berbers GAM; Ruijs WLM; van Sorge NM; de Melker HE; Knol MJ
    Clin Infect Dis; 2022 Jul; 74(12):2173-2180. PubMed ID: 34525199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Neisseria meningitidis in saliva and oropharyngeal samples from college students.
    Miellet WR; Mariman R; Pluister G; de Jong LJ; Grift I; Wijkstra S; van Logchem EM; van Veldhuizen J; Immink MM; Wijmenga-Monsuur AJ; Rots NY; Sanders EAM; Bosch T; Trzciński K
    Sci Rep; 2021 Nov; 11(1):23138. PubMed ID: 34848796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.